以金黄色葡萄球菌致病因素为靶点的免疫疗法研究进展
Research advances in immunotherapy targeting the pathogenic factors of Staphylococcus aureus
摘要
金葡菌是引起皮肤和软组织感染的主要病原菌,严重感染者可引起致命性的肺炎、血流感染、感染性心内膜炎以及化脓性关节炎和骨髓炎等。2011年中国CHINET细菌耐药性监测结果显示,临床分离的革兰阳性菌中金葡菌检出率最高,
出处
《中国感染与化疗杂志》
CAS
北大核心
2013年第6期491-494,共4页
Chinese Journal of Infection and Chemotherapy
基金
中华医学会临床医学科研专项资金项目(10030160238)
参考文献22
-
1胡付品,朱德妹,汪复,蒋晓飞,杨青,徐英春,张小江,孙自镛,陈中举,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,单斌,杜艳,徐元宏,沈继录,张泓,孔菁,卓超,苏丹虹,张朝霞,季萍,胡云建,艾效曼,黄文祥,贾蓓,魏莲花,吴玲.2011年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2012,12(5):321-329. 被引量:526
-
2Brink AJ. Does resistance in severe infections caused by me- thicillin-resistant Staphylococcus aureus give you the t 19 creeps .[J]. Curt ()pin Crit Care, 2012,18(5) :451 459.
-
3Ythier M, Reseh G, Waridel P, et al. Proteomie and tran scriptomic profiling of Staphylococcus aureus surface LPX TG proteins: correlation with agr genotypes and adherence phenotypes[J]. Mol Cell Proteomics, 2012, 11(11):1123 1139.
-
4Verkaik NJ, van Wamel WJ, van Belkum A. Immunothera- peutic approaches against Staphylococcus aureus [J]. Immu notherapy, 2011,3(9) :1063-1073.
-
5Josefsson E, Hartford O, O'Brien L, et al. Protection a gainst experimental Staphylococcus aureus arthritis by vacci nation with clumping factor A, a novel virulence determinant [J]. J Infect Dis, 2001,184(12):1572-1580.
-
6Weems JJ Jr, Steinberg JP, Filler S, et al. Phase II, rando- mi zed, double-blind, multicenter study comparing the safety and pharrnacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus baeteremia[J]. Antirnicrob Agents Chemother, 2006,50(8) :2751-2755.
-
7Ebert T, Smith S, Pancari G, et al. A fully human mono- clonal antibody to Staphylococcus aureus iron regulated sur face determinant B (IsdB) with functional activity in vitro and invivo[J]. Hum Antibodies, 2010,19(4):113-128.
-
8Harro C, Betts R, Orenstein W, et al. Safety and immunoge nicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans[J]. Clin Vaccine Immonol, 2010,17(12) : 1868 1874.
-
9Adhikari RP, Karauzum H, Sarwar J, et al. Novel structu rally designed vaccine for S. aureus alpha-hemolysin: protec tion against bacteremia and pneumonia[J]. PLoS One, 2012, 7(6), e38567.
-
10Proctor RA. Is there a future for a Staphylococcus aureus vaccine? [J] Vaccine, 2012,30(19) :2921-2927.
二级参考文献8
-
1Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
-
2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
-
3Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.
-
4Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis-emergence of resistance in aerobic faecal gram-negative bacteria of in patients, but not among strains causing infection after elective colorectal procedures [J ]. Scand J Infect Dis, 1993, 25(6) :725-733.
-
5Andaker L, Burman LG, Eklund A, et al. Fosfomycin/met- ronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective coloreetal surgery: a randomised double blind multicentre trial in 517 patients[J]. Eur J Surg, 1992, 158(3):181 185.
-
6Nohr M, Andersen JC, Juul-Jensen KE. Prophylactic single dose fosfomycin and metronidazole compared with neomycin, haeitraein, metronidazole and ampicillin in elective colorectal operations[J]. Acta Chir Seand, 1990, 156(3):223-230.
-
7Lindhagen J, Hadziomerovic A, Nordlung S, et al. Comparison of systemic prophylaxis with metronidazole-fosfomycin and met- ronidazole-cephalothin in elective colorectal surgery[J]. Acta Chir Scand, 1981, 147(4):277-283.
-
8汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,孙宏莉,胡云健,艾效曼,俞云松,杨青,孙自镛,简翠,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华.2007年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2008,8(5):325-333. 被引量:305
共引文献525
-
1许青天.临床微生物检验和细菌耐药性监测探讨[J].医学信息(医学与计算机应用),2014,0(21):563-563. 被引量:7
-
2陈默蕊,杨立业,杨惠钿,林敏.我院2012年儿科呼吸道标本519株病原菌分布及耐药性监测结果[J].黑龙江医学,2013,37(9):788-791. 被引量:4
-
3黄絮,李刚.重症监护病房多重耐药菌定植与医院感染的关系[J].中华临床感染病杂志,2013,6(6):355-358. 被引量:8
-
4谭丽丽.住院患儿下呼吸道感染病原菌耐药性分析[J].中国医药科学,2014,4(9):74-76. 被引量:1
-
5汝玲.2011年我院临床常见病原菌耐药监测结果对比分析[J].中南药学,2013,11(1):72-75. 被引量:3
-
6张阮章,卢月梅,胡玉华,吴劲松,吴伟元,李文清,王沙燕.泌尿系感染产ESBLs大肠埃希菌基因分型[J].中国微生态学杂志,2013,25(3):323-324.
-
7李茜,胡庆丰,孙仁华.重症监护病房肺炎克雷伯菌的分布及耐药性变迁[J].健康研究,2013,33(2):116-119. 被引量:5
-
8张阮章,卢月梅,吴劲松,胡玉华,吴伟元,李文清,王沙燕.产ESBLs大肠埃希菌的AmpC基因型分析[J].中国微生态学杂志,2013,25(4):425-426. 被引量:3
-
9陈国华,王斌,曲一航.大肠埃希菌引起血流感染现状分析[J].中国实用医药,2013,8(10):6-7. 被引量:2
-
10周吉华,陆国平,陆铸今.儿科重症监护病房机械通气相关肺部感染的病原菌调查及耐药性分析[J].中国医药科学,2013,3(7):12-15. 被引量:6
-
1李立华.化脓性关节炎355例厌氧菌培养及药敏结果分析[J].中华医院感染学杂志,2013,23(12):3037-3037.
-
2金涛,李璐,金卉,徐立,周峰.金黄色葡萄球菌感染致化脓性关节炎的临床研究[J].中华医院感染学杂志,2015,25(19):4418-4420. 被引量:10
-
3王艳海,巴特尔.耐甲氧西林金黄色葡萄球菌的研究进展[J].中国煤炭工业医学杂志,2012,15(8):1301-1304. 被引量:6
-
4史利宁,邵海枫,王卫萍,张小卫.肠炎沙门菌致化脓性关节炎1例[J].中国感染与化疗杂志,2006,6(5):344-344. 被引量:1
-
5姚丹,余方友,陈坚,张雪青,章圣辉,曾云祥,王良兴.金黄色葡萄球菌杀白细胞素基因的检测[J].中华检验医学杂志,2010,33(2):154-156. 被引量:8
-
6鲁俊峰.社区获得性感染中可见高比例耐甲氧西林金黄色葡萄球菌[J].传染病网络动态,2005(2):2-3.
-
7罗湘蓉,班丽佳,李红凌,黄维锦.贵阳地区2007-2008年流感嗜血杆菌季节分布及药敏分析[J].贵州医药,2009,33(12):1127-1128. 被引量:2
-
8邵菊芳(编译).在儿童中USA300是导致金黄色葡萄球菌性化脓性关节炎主要的基因型[J].中华急诊医学杂志,2010,19(1):10-10.
-
9程明珠.氧氟沙星与头孢氨苄两药在治疗皮肤和软组织感染时疗效相同[J].四川生理科学杂志,1993,0(Z1):31-31.
-
10唐芳根,袁芬连,刘家开,龙泉.膝类风湿性关节炎合并麻疹孪生球菌致化脓性关节炎1例报告[J].南方医科大学学报,2012,32(3):437-438. 被引量:8